Test and teach. Number one hundred and one: Part 1.
Westerman
D A
DA
Department of Pathology, Peter MacCallum Cancer Institute, Melbourne, Australia.
Juneja
S K
SK
D000368:Aged; D015703:Antigens, CD / Q000032:analysis; D000970:Antineoplastic Agents / Q000627:therapeutic use; D001854:Bone Marrow Cells / Q000473:pathology; D017338:Cladribine / Q000627:therapeutic use; D003937:Diagnosis, Differential; D006801:Humans; D016130:Immunophenotyping; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007943:Leukemia, Hairy Cell / Q000175:diagnosis* / Q000188:drug therapy / Q000601:surgery; D017254:Leukemic Infiltration / Q000473:pathology; D008223:Lymphoma / Q000175:diagnosis; D008297:Male; D013156:Splenectomy; D013160:Splenic Neoplasms / Q000175:diagnosis; D016896:Treatment Outcome
D015703:Antigens, CD; D000970:Antineoplastic Agents; D007166:Immunosuppressive Agents; D017338:Cladribine